Work

Comparative analysis of miR-126 and EGFL7 in angiogenesis

Year: 2025
Type: dissertation
Abstract: Angiogenesis is a fundamental process orchestrated by complex regulatory networks. miR-126 and EGFL7 play pivotal roles in angiogenesis and share a genomic locus. However, their individual contributions to angiogenesis remain unclear. The systematic comparison of their angiogenic roles in isolation has been hindered by the lack of suitable models. More-over, previous studies have primarily relied on conventional knockout models, which fail to distinguish acute regulatory effects from long-term compensatory adaptations. Addi-tionally, double knockouts or incomplete knockouts induced misleading results. These limi-tations complicate the interpretation of their distinct contributions. This study systematically investigated the vascular roles of miR-126 and EGFL7 using mu-rine models with single knockout of either miR-126 or EGFL7 within the neonatal retinal model. To achieve this, we generated and validated four knockout models: miR-126 con-sti-tutive knockout, miR-126 inducible endothelial cell (EC)-specific knockout, EGFL7 con-stitutive knockout, and EGFL7 inducible EC-specific knockout. By integrating phenotypic analyses with transcriptomic profiling, we delineated their contributions to angiogenesis. Retinal angiogenesis was assessed at post-natal day 5 to evaluate vascular density, re-gression, and proliferation. Additionally, bulk RNA sequencing of retinal ECs was performed to identify differentially expressed genes (DEGs) and pathways associated with miR-126 and EGFL7 deficiency and to compare their similarities and differences. The results showed an EC-specific expression of miR-126 and EGFL7 mRNA in the retina. Both knockout models exhibited overlapping and distinct phenotypic effects on vascular develop-ment. miR-126 knockout resulted in severe vascular abnormalities, including re-duced vas-cular density, impaired endothelial proliferation, defective branching and regres-sion in both constitutive and inducible EC-specific knockout models. EGFL7 knockout ex-hibited distinct effects, with inducible EC-specific knockout reducing vascular density and branching but not affecting proliferation and regression, whereas constitutive knockout showed no measurable vascular defects, suggesting that potential compensatory mecha-nisms mitigate its loss. Transcriptomic analysis revealed predominantly distinct, yet partially overlapping, regulatory mechanisms for miR-126 and EGFL7: miR-126 majorly regulates angiogenic proliferation and endothelial metabolism through angiopoietin-2 (Angpt2), angiopoietin-like 4 (Angptl4), and cytotoxic T-lymphocyte-associated protein 2 alpha (Ctla2a), whereas EGFL7primarily modulates extracellular matrix (ECM) remodeling and endothelial adhesion via tissue inhib-itor of metalloproteinase 2 (Timp2) and cellular com-munication network factor 1 (Ccn1). Nervertheless, 16 overlapping DEGs were identified in miR-126 and EGFL7 inducible knockouts, mostly linked to ECM regulation. Key genes include tissue inhibitor of metallo-proteinase 3 (Timp3) andextracellular matrix protein 1 (Ecm1). This limited overlap suggests that, while miR-126 and EGFL7 contribute to vascular regulation through different molecular pathways, they may share a minor but functionally relevant subset of targets involved in ECM homeostasis. The absence of vascular phenotype defects in the constitutive EGFL7 knockout model correlates with the lack of enriched angiogenesis-related pathways and minor transciptomics changes. Hypothetically, the loss of EGFL7 might be functionally compensated, potentially through the downregulation of the angiogenesis inhibitor sprouty-related EVH1 domain-containing protein 1 (Spred-1) and insulin-like growth factor binding protein 4 (Igfbp4). Moreover, to explore their therapeutic potential, we conducted a pilot study using glioma models, a highly vascularized tumor. Intracranially implanted gliomas were analyzed to as-sess miR-126 expression pattern and the impact of miR-126 deletion on tumor growth and survival. In both murine and PDOX glioma models, miR-126 expression was consistent with the physiological retina model, mainly expressed in ECs. miR-126 knockout in the mu-rine model led to accelerated tumor growth and reduced survival, whereas previous studies demonstrated that EGFL7 deletion suppresses glioma progression with an anti-angiogenic effect, indicating their opposing roles. In summary, these findings demonstrate pivotal and independent roles of both moecules in angiogenesis. Despite some overlapping phenotype parameters and transcriptomic si-mi-larities, their mechanims in regulating angiogenesis are mainly different. miR-126 mainly acts as an EC homeostatic regulator and EGFL7 as a structural modulator of blood vessel stability. The functional consequences of miR-126 knockout cannot be compensated, high-lighting its great potential as a therapeutic target. These insights provide a mechanistic framework for targeting miR-126 and EGFL7 for angiogenesis-related diseases, including glioma.
Author: Hu, Aiyan
Language: English
Open Access status: green
OpenAlex ID: W7114826548
Cites: 105
Cited by:
Related to: 10